Get the Stockscreener App
11.41
2.73%
-0.32
After Hours:
11.41
Immatics N V stock is traded at $11.41, with a volume of 342.24K.
It is down -2.73% in the last 24 hours and up +2.89% over the past month.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
See More
Previous Close:
$11.73
Open:
$11.73
24h Volume:
342.24K
Relative Volume:
1.07
Market Cap:
$1.21B
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-9.623
EPS:
-1.1857
Net Cash Flow:
$-13.78M
1W Performance:
-3.06%
1M Performance:
+2.89%
6M Performance:
+8.56%
1Y Performance:
-1.47%
1-Day Range:
$11.34
$11.83
1-Week Range:
$11.34
$11.97
52-Week Range:
$7.15
$13.77
Immatics N V Stock (IMTX) Company Profile
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Forefront Analytics LLC Invests $139,000 in Immatics (NASDAQ:IMTX) - Defense World
Frazier Life Sciences Management L.P. Invests $13.39 Million in Immatics (NASDAQ:IMTX) - MarketBeat
Immatics (NASDAQ:IMTX) Shares Sold by Affinity Asset Advisors LLC - MarketBeat
Affinity Asset Advisors LLC Sells 50,000 Shares of Immatics (NASDAQ:IMTX) - Defense World
HighVista Strategies LLC Makes New Investment in Immatics (NASDAQ:IMTX) - MarketBeat
HighVista Strategies LLC Acquires New Shares in Immatics (NASDAQ:IMTX) - Defense World
Immatics N.V.'s (NASDAQ:IMTX) Price Is Out Of Tune With Revenues - Simply Wall St
KKR and Impilo complete acquisition of Immedica Pharma - Marketscreener.com
(IMTX) On The My Stocks Page - Stock Traders Daily
Leerink Partnrs Comments on Immatics' FY2024 Earnings (NASDAQ:IMTX) - MarketBeat
France’s MK2 Films Secures Slate Financing Deal With Fund Management Company Ipr.Vc to Fast-Track Production, Acquisition - imdb
Immatics to Post FY2024 Earnings of ($1.03) Per Share, Leerink Partnrs Forecasts (NASDAQ:IMTX) - Defense World
IK Multimedia launches “feature-rich, professional version” of its iLoud Micro Monitor - MusicTech
IK Multimedia promises studio-grade sound in a portable package with the iLoud Micro Monitor Pros - Yahoo Entertainment
I-Mab (NASDAQ:IMAB) Rating Reiterated by HC Wainwright - Defense World
Intuitive Machines Rockets Higher On NASA Contract - Seeking Alpha
You might want to take a look at Immatics N.V (IMTX) now - SETE News
ESMO 2024: BMS cuts ties as Immatics regains full rights to bispecific - Pharmaceutical Technology
AM Expands Beyond 3D Printing at IMTS 2024 - 3DPrint.com
Immatics (NASDAQ:IMTX) Stake Lessened by Sofinnova Investments Inc. - MarketBeat
Bristol Myers ends cancer drug collab with Immatics - The Pharma Letter
ESMO 2024: BMS cuts ties as Immatics regains full rights to bispecific - Yahoo Finance
Immunic (NASDAQ:IMUX) Raised to Strong-Buy at EF Hutton Acquisition Co. I - MarketBeat
Pair of radiopharma deals sees Sanofi dive into 212Pb as ITM gets another 177Lu program - BioCentury
Immatics presents TCER IMA401 data at ESMO - TipRanks
Immatics collaboration with Bristol Myers ends due to portfolio prioritization - TipRanks
ESMO: Bristol Myers axes Immatics' bispecific after $150M bet - Fierce Biotech
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update - StockTitan
Immatics Presents Clinical Proof-of-Concept Data from - GlobeNewswire
Leerink Partners Likes “Risk/Reward” of Immunic’s CALLIPER Readout - TipRanks
Immatics (NASDAQ:IMTX) Shares Acquired by TD Asset Management Inc - Defense World
IMTXImmatics N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Check out these key findings about Immatics N.V (IMTX) - SETE News
Immatics N.V (IMTX)’s stock rises to 11.43 per share - US Post News
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024 - GlobeNewswire
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024 - StockTitan
Immatics (NASDAQ:IMTX) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Immatics' (IMTX) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
(IMTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Immatics (NASDAQ:IMTXW) Short Interest Down 5.9% in August - Defense World
JAZZ: 3 Oncology Stocks With Major Upside - StockNews.com
Investor’s Toolkit: Key Ratios for Assessing Immatics N.V (IMTX)’s Performance - The Dwinnex
Immatics (NASDAQ:IMTXW) Short Interest Update - Defense World
Cantor Fitzgerald Weighs in on Immatics' FY2024 Earnings (NASDAQ:IMTX) - MarketBeat
IMTXW (Immatics NV) Cash-to-Debt : 30.50 (As of Jun. 2024) - GuruFocus.com
FY2024 Earnings Forecast for Immatics (NASDAQ:IMTX) Issued By Cantor Fitzgerald - Defense World
Immatics NV (FRA:4A3) 3-Year EPS without NRI Growth Rate : 11.70% (As of Jun. 2024) - GuruFocus.com
Immatics NV (FRA:4A3) Price-to-Free-Cash-Flow : N/A (As of Aug. 17, 2024) - GuruFocus.com
Leerink Partnrs Analysts Cut Earnings Estimates for Immatics (NASDAQ:IMTX) - Defense World
Leerink Partnrs Analysts Cut Earnings Estimates for Immatics (NASDAQ:IMTX) - MarketBeat
Immatics Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):